Ajjan, RA, Hensor, EMA, Del Galdo, F et al. (13 more authors) (2022) Oral 11β-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomised controlled trial. European Journal of Endocrinology. ISSN 0804-4643
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2022 The authors 2022. This is an author produced version of an article published in European Journal of Endocrinology. Uploaded in accordance with the publisher's self-archiving policy. |
Dates: |
|
Institution: | The University of Leeds |
Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM) > Discovery & Translational Science Dept (Leeds) |
Funding Information: | Funder Grant number MRC (Medical Research Council) MC_PC_15046 |
Depositing User: | Symplectic Publications |
Date Deposited: | 07 Feb 2022 11:35 |
Last Modified: | 07 Feb 2022 11:35 |
Status: | Published online |
Publisher: | BioScientifica |
Identification Number: | 10.1530/EJE-21-1197 |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:183255 |